As Trump proposes NIH cuts, a top Merck executive sees fragility in a ‘super-highway for biomedicine’
As Trump proposes NIH cuts, a top Merck executive sees fragility in a ‘super-highway for biomedicine’ R&D chief and other biopharma leaders stop short of criticizing the administration CHICAGO — Amid ongoing uncertainty around funding for the National Institutes of Health, and what it could mean for U.S. innovation, a top Merck executive […]